[{"name":"药物研究","count":2755,"id":1},{"name":"临床医药","count":2690,"id":2},{"name":"药事组织","count":2618,"id":3},{"name":"药物鉴定","count":2523,"id":4},{"name":"临床研究","count":1776,"id":5},{"name":"传统医药","count":1386,"id":6},{"name":"制剂技术","count":1047,"id":7},{"name":"检验检测","count":968,"id":8},{"name":"综述报告","count":910,"id":9},{"name":"药事管理","count":838,"id":10},{"name":"Pharmaceutical Administration","count":786,"id":11},{"name":"药学论著","count":755,"id":12},{"name":"Pharmacy Articles","count":748,"id":13},{"name":"Inspection and Test","count":674,"id":14},{"name":"Clinical Research","count":598,"id":15},{"name":"食品药品监管","count":537,"id":16},{"name":"实验研究","count":453,"id":17},{"name":"药业论坛","count":433,"id":18},{"name":"临床药学","count":361,"id":19},{"name":"药学专论","count":360,"id":20},{"name":"药品检测","count":351,"id":21},{"name":"药学监护","count":300,"id":22},{"name":"Pharmaceutical Care","count":299,"id":23},{"name":"个案报道","count":296,"id":24},{"name":"药品评价","count":295,"id":25},{"name":"Drug Evaluation","count":292,"id":26},{"name":"药品监管","count":269,"id":27},{"name":"临床交流","count":255,"id":28},{"name":"合理用药","count":227,"id":29},{"name":"热门话题","count":221,"id":30},{"name":"综述","count":187,"id":31},{"name":"本刊视线","count":174,"id":32},{"name":"药房管理","count":169,"id":33},{"name":"Clinical Study","count":164,"id":34},{"name":"Review","count":164,"id":35},{"name":"咨询服务","count":144,"id":36},{"name":"药业纵横","count":130,"id":37},{"name":"药业短波","count":126,"id":38},{"name":"药学研讨","count":125,"id":39},{"name":"Quality Research","count":124,"id":40},{"name":"质量研究","count":124,"id":41},{"name":"药业专论","count":120,"id":42},{"name":"Monograph on Pharmaceutical Industry","count":116,"id":43},{"name":"Experiment Research","count":115,"id":44},{"name":"专论","count":100,"id":45},{"name":"中药天地","count":92,"id":46},{"name":"Pharmaceutical Services","count":84,"id":47},{"name":"新冠肺炎专题","count":84,"id":48},{"name":"药学服务","count":84,"id":49},{"name":"本刊特稿","count":80,"id":50},{"name":"Pharmacy Administration","count":75,"id":51},{"name":"Special Topic on the COVID-19","count":71,"id":52},{"name":"卷首篇","count":71,"id":53},{"name":"医院药学","count":67,"id":54},{"name":"Drug Research","count":59,"id":55},{"name":"医院制剂","count":55,"id":56},{"name":"管理科学","count":55,"id":57},{"name":"本刊视点","count":54,"id":58},{"name":"科技视野","count":49,"id":59},{"name":"Monograph","count":42,"id":60},{"name":"个案","count":38,"id":61},{"name":"药学教育","count":36,"id":62},{"name":"Drug Identification","count":33,"id":63},{"name":"Special Report","count":33,"id":64},{"name":"监管实践","count":33,"id":65},{"name":"药业大观","count":33,"id":66},{"name":"药政监管","count":32,"id":67},{"name":"Pharmaceutical Education","count":31,"id":68},{"name":"医药质量","count":31,"id":69},{"name":"名厂名店","count":30,"id":70},{"name":"药市观潮","count":29,"id":71},{"name":"临定医药","count":28,"id":72},{"name":"特别策划","count":28,"id":73},{"name":"赃 药事组织","count":27,"id":74},{"name":"信息集锦","count":26,"id":75},{"name":"研究 -- 实验研究","count":26,"id":76},{"name":"营销视屏","count":25,"id":77},{"name":"药业英才","count":24,"id":78},{"name":"临床医学","count":23,"id":79},{"name":"特别报道","count":17,"id":80},{"name":"Clinical Medicine","count":16,"id":81},{"name":"赃 药物鉴定","count":16,"id":82},{"name":"NMPA Key Laboratory·Quality Study of Narcotic Drugs and Psychotropic Substances","count":15,"id":83},{"name":"医药沙龙","count":15,"id":84},{"name":"国家药监局重点实验室·麻精药品质量研究专题","count":15,"id":85},{"name":"传媒广场","count":14,"id":86},{"name":"研究 -- 临床研究","count":14,"id":87},{"name":"药业名家","count":14,"id":88},{"name":"行业广角","count":14,"id":89},{"name":"Special Topic on the COVID - 19","count":13,"id":90},{"name":"卷首语","count":13,"id":91},{"name":"用药分析","count":13,"id":92},{"name":"药业文萃","count":13,"id":93},{"name":"一月回眸","count":12,"id":94},{"name":"个例报道","count":11,"id":95},{"name":"企业管理","count":11,"id":96},{"name":"医药质量管理","count":11,"id":97},{"name":"药物签定","count":11,"id":98},{"name":"企业家园地","count":10,"id":99},{"name":"Traditional Medicine","count":8,"id":100},{"name":"企业园地","count":8,"id":101},{"name":"本刊专访","count":8,"id":102},{"name":"特约专稿","count":8,"id":103},{"name":"综合报告","count":8,"id":104},{"name":"药业动态","count":8,"id":105},{"name":"药业鉴定","count":8,"id":106},{"name":"Inspectaon and Test","count":7,"id":107},{"name":"Pharmacy Articlesc","count":7,"id":108},{"name":"Clinical Researck","count":6,"id":109},{"name":"学习园地","count":6,"id":110},{"name":"市场分析","count":6,"id":111},{"name":"文件选录","count":6,"id":112},{"name":"计算机应用","count":6,"id":113},{"name":"读者·作者·编者","count":6,"id":114},{"name":"Pharmaceutical Administrationc","count":5,"id":115},{"name":"Traditional medicine","count":5,"id":116},{"name":"研究 -- 检验检测","count":5,"id":117},{"name":"药学研究","count":5,"id":118},{"name":"药物警戒与用药安全专题","count":5,"id":119},{"name":"\"Internet+\" Pharmaceutical Care","count":4,"id":120},{"name":"Clinical Practice of Pharmaceutical Care","count":4,"id":121},{"name":"Construction of Licensed Pharmacist Team","count":4,"id":122},{"name":"Information Science of Research and Development Progress in Synthetic Biology","count":4,"id":123},{"name":"Innovation and Development of Licensed Pharmacists from the Perspective of the National Two Sessions","count":4,"id":124},{"name":"Inspection and Testc","count":4,"id":125},{"name":"Pharmaceutical Monographs","count":4,"id":126},{"name":"Quality Improvment of Community Pharmaceutical Care","count":4,"id":127},{"name":"“互联网+”药学服务专题","count":4,"id":128},{"name":"两会视角下执业药师创新与发展专题","count":4,"id":129},{"name":"医院论坛","count":4,"id":130},{"name":"合成生物学研发进展情报学专题","count":4,"id":131},{"name":"执业药师队伍建设专题","count":4,"id":132},{"name":"社区药学服务质量提升专题","count":4,"id":133},{"name":"药学监护临床实践专题","count":4,"id":134},{"name":"赃 制剂技术","count":4,"id":135},{"name":"食品药品监督","count":4,"id":136},{"name":"Development Trend of Cutting - Edge Patent Technologies in Medicine","count":3,"id":137},{"name":"Development Trends in Biopharmaceutical Science and Technology in the Beijing-Tianjin-Hebei Region","count":3,"id":138},{"name":"Drug Evaluatiou","count":3,"id":139},{"name":"Preparation Technology","count":3,"id":140},{"name":"Progress in the R&D of Anti - COVID - 19 Drugs","count":3,"id":141},{"name":"Quality Improvement of Drug Clinical Trials","count":3,"id":142},{"name":"Special Report on Hospital Intelligent Pharmacy","count":3,"id":143},{"name":"个案报告","count":3,"id":144},{"name":"京津冀生物医药科技发展态势专题","count":3,"id":145},{"name":"医药前沿专利技术发展态势研究专题","count":3,"id":146},{"name":"医院智慧药学专题","count":3,"id":147},{"name":"声明","count":3,"id":148},{"name":"新冠肺炎治疗药物研发进展专题","count":3,"id":149},{"name":"法制经纬","count":3,"id":150},{"name":"环球看台","count":3,"id":151},{"name":"综 述","count":3,"id":152},{"name":"药业巡礼","count":3,"id":153},{"name":"药事 -- 合理用药","count":3,"id":154},{"name":"药事 -- 监管实践","count":3,"id":155},{"name":"药事 -- 药房管理","count":3,"id":156},{"name":"药物临床研究质量提升专题","count":3,"id":157},{"name":"Drug Evaluationc","count":2,"id":158},{"name":"总目录","count":2,"id":159},{"name":"新药评介","count":2,"id":160},{"name":"热点话题","count":2,"id":161},{"name":"药物论坛","count":2,"id":162},{"name":"附录","count":2,"id":163},{"name":"Pharmaceutical Forum","count":1,"id":164},{"name":"上情下达","count":1,"id":165},{"name":"专家论药","count":1,"id":166},{"name":"传媒产场","count":1,"id":167},{"name":"信息","count":1,"id":168},{"name":"图片新闻","count":1,"id":169},{"name":"大家谈","count":1,"id":170},{"name":"新药评价","count":1,"id":171},{"name":"曝光台","count":1,"id":172},{"name":"本刊特别报道","count":1,"id":173},{"name":"本刊郑重声明","count":1,"id":174},{"name":"短讯","count":1,"id":175},{"name":"研究 -- 管理科学","count":1,"id":176},{"name":"简讯","count":1,"id":177},{"name":"综述报道","count":1,"id":178},{"name":"药业枞横","count":1,"id":179},{"name":"药物专论","count":1,"id":180},{"name":"调查报告","count":1,"id":181},{"name":"赃赃 综述报告","count":1,"id":182}]
